Feline strongyloidiasis: An insight into its global prevalence and transmission cycle.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Prevalence and molecular characterization ofInternational journal for parasitology. Parasites and wildlife · 2026
   Article
2. Taxonomy ofParasitology · 2026
   Review
3. Detection of intestinal parasites in leopard cat fecal samples using shotgun metagenomics.Parasites, hosts and diseases · 2025
   Article
4. Human, canine and feline strongyloidiasis: beyondParasitology · 2025
   Review
5. Cutaneous Larva Migrans Refractory to Therapy with Ivermectin: Case Report and Review of Implicated Zoonotic Pathogens, Epidemiology, Anthelmintic Drug Resistance and Therapy.Tropical medicine and infectious disease · 2025
   Article
6. Risk of Environmental Contamination by Gastrointestinal Parasites in Public Areas of the Central Plateau Microregion of Brazil: A Public Health Concern.Pathogens (Basel, Switzerland) · 2025
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as